DGX Return on Equity (ROE) Analysis
Higher than 67% of Healthcare sector peers
Updated 581h ago·SEC filings & market data
Key Takeaway
Return on equity (ROE) measures how much profit a company generates from each dollar of shareholder equity; at 14.6%, Quest Diagnostics earns $14.60 for every $100 of equity invested.
Sector Performance
67th percentileDGX
14.6%
Sector Median
11.3%
Sector Avg
72.2%
Prior Period
14.5%(Jul 2026)
Deep Analysis
Return on equity (ROE) measures how much profit a company generates from each dollar of shareholder equity; at 14.6%, Quest Diagnostics earns $14.60 for every $100 of equity invested.
This is above the healthcare sector median of 8.9%, placing the company in the 66th percentile of its peers, indicating better-than-average profitability. The year-over-year change is not available, while the quarter-over-quarter change is +0.7%, with the most recent values showing a slight rise from 14.5% to 14.6%. The lack of a longer trend makes it difficult to judge momentum, but the high relative level suggests efficient use of capital with limited immediate downside. The combination of an above-median ROE and only a small quarterly increase implies steady performance rather than accelerating opportunity. This metric supports the overall NEUTRAL verdict, as the return is solid but not exceptional enough to justify a bullish or bearish tilt.
Frequently Asked Questions
What does the Return on Equity (ROE) tell investors about DGX?
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
How is the Return on Equity (ROE) calculated?
Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.
How does DGX's Return on Equity (ROE) compare to its sector?
DGX's Return on Equity (ROE) of 14.6% compares to a Healthcare sector median of 11.3%, placing it in the 67th percentile.
Who are DGX's closest peers by Return on Equity (ROE)?
The closest Healthcare peers by Return on Equity (ROE) include: ABT (12.5%), ALGN (10.1%), TMO (13.5%), TECH (9.0%), VEEV (13.9%).
Learn More About Return on Equity (ROE)
The Formula
Net Income / Shareholders' Equity
Why It Matters
ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.
Master DGX's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full DGX research report →DGX
14.6%
Sector Median
11.3%
Sector Avg
72.2%
How DGX's Return on Equity (ROE) compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.